跳到正文
原文
Alnylam Pharmaceuticals· @Alnylam · X·· 21 天前AI 评分25
AI 导读

Alnylam与Inceptive的战略合作正在将RNAi专业能力与先进AI模型相结合,以加速下一代RNAi疗法的设计。我们的CEO Dr. Yvonne Greenstreet与Inceptive CEO兼联合创始人Jakob Uszkoreit近日坐下来讨论了这两家公司为何走到一起,以及我们希望这一合作能带来什么。 ➡️ 阅读更多并观看完整采访:https://go-alnylam.com/45XcobF

正文

Alnylam's strategic collaboration with Inceptive is combining RNAi expertise and advanced AI models to accelerate the design of next-generation RNAi therapeutics. Our CEO Dr. Yvonne Greenstreet and Inceptive CEO and Co-founder Jakob Uszkoreit recently sat down to discuss why the two companies came together and what we hope the collaboration will yield.

➡️ Read more and watch the full interview: https://go-alnylam.com/45XcobF

来源:Alnylam Pharmaceuticals · x.com